The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 16, 2018
Filed:
Jul. 31, 2017
Imidazopyrimidine and imidazotriazine derivative, and pharmaceutical composition comprising the same
SK Biopharmaceuticals Co., Ltd., Seoul, KR;
Chun Eung Park, Daejeon, KR;
Young Koo Jang, Daejeon, KR;
Yong Je Shin, Daejeon, KR;
Ji Yeon Kim, Daejeon, KR;
Seung Mo Ham, Daejeon, KR;
Yong Gil Kim, Daejeon, KR;
Hye Kyung Min, Daejeon, KR;
Soo Bong Cha, Daejeon, KR;
Hyo Jun Jung, Daejeon, KR;
Ju Young Lee, Daejeon, KR;
Seung Nam Han, Daejeon, KR;
Jin Yong Chung, Daejeon, KR;
Eun Ju Choi, Daejeon, KR;
Chan Mi Joung, Daejeon, KR;
Jong Sil Park, Daejeon, KR;
Ji Won Lee, Daejeon, KR;
Nahm Ryune Cho, Daejeon, KR;
Eun Ju Ryu, Daejeon, KR;
Cheol Young Maeng, Daejeon, KR;
SK BIOPHARMACEUTICALS CO., LTD., Seoul, KR;
Abstract
The present disclosure provides a compound of Chemical Formula (1) or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising the same: The compound of Chemical Formula (1) or pharmaceutically acceptable salt thereof acts as a positive allosteric modulator of metabotropic glutamate receptor subtype 5 (mGluR5), thereby being useful in the prevention or treatment of disorder mediated by glutamate dysfunction and mGluR5.